Esketamine: A Possible Adjunctive Therapy for Treatment Resistant Depression.
Where this comes from
- Record sourced from PubMed, PMID 41720504.
- Also identified by DOI 10.3122/jabfm.2025.250369R0 and PMC identifier 12978794.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
If available in one's practice area, augmenting current medication therapy with esketamine results in greater rates of remission for treatment resistant depression as compared with quetiapine<sup>1</sup>.
Medical subject headings
- Depressive Disorder, Treatment-Resistant
- Antidepressive Agents
- Ketamine